HomeSOPH • NASDAQ
add
Sophia Genetics SA
Previous close
$3.58
Day range
$3.48 - $3.61
Year range
$2.70 - $7.37
Market cap
237.69M USD
Avg Volume
29.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 15.81M | 5.01% |
Operating expense | 25.78M | -14.33% |
Net income | -15.19M | 28.99% |
Net profit margin | -96.11 | 32.38% |
Earnings per share | -0.15 | 39.07% |
EBITDA | -13.76M | 24.71% |
Effective tax rate | -1.07% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 105.40M | -29.05% |
Total assets | 181.10M | -18.86% |
Total liabilities | 59.65M | 15.83% |
Total equity | 121.44M | — |
Shares outstanding | 66.21M | — |
Price to book | 1.96 | — |
Return on assets | -20.76% | — |
Return on capital | -24.91% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -15.19M | 28.99% |
Cash from operations | -10.00M | 3.14% |
Cash from investing | -1.96M | -7.76% |
Cash from financing | 13.35M | 2,256.22% |
Net change in cash | 1.66M | 113.60% |
Free cash flow | -5.63M | 14.35% |
About
Sophia Genetics SA is a data-driven medicine software company with headquarters in Lausanne, Switzerland and Boston, Massachusetts. It provides genomic and radiomic analysis for hospitals, laboratories, and biopharma institutions. The company was ranked among the 50 smartest companies by the MIT Technology Review in 2017. The company went public on the Nasdaq in 2021, floating at $1.1B. Wikipedia
Founded
Jan 1, 2011
Website
Employees
430